文献速递腹部儿科影像MR

钆塞酸增强MRI鉴别儿童局灶性结节性增生与肝细胞腺瘤

Gadoxetic acid-enhanced MRI in differentiating focal nodular hyperplasia from hepatocellular adenoma in children.
PubMed 文献 · Br J Radiol · 2025-01-01

回顾性纳入22例儿童肝脏病变患者(肝细胞腺瘤6例、局灶性结节性增生16例),评估钆塞酸增强MRI鉴别两者的诊断效能。肝细胞腺瘤最特异的非增强特征是病灶内脂肪,肝胆期所有局灶性结节性增生均呈等或高信号而肝细胞腺瘤除1例外均呈低信号。SIRpost-pre和LLCER的敏感度和特异度均达100%。

要点

  • 病灶内脂肪是肝细胞腺瘤最特异的非增强MRI特征,本组所有肝细胞腺瘤含脂肪而局灶性结节性增生均无。
  • 肝胆期局灶性结节性增生均呈等或高信号,肝细胞腺瘤除1例外均呈低信号,但存在重叠。
  • SIRpost-pre和LLCER两个定量指标鉴别两者的敏感度和特异度均为100%。

核心结论

  • 钆塞酸增强MRI肝胆期摄取对鉴别儿童局灶性结节性增生与肝细胞腺瘤有较高诊断准确率,但存在重叠;SIRpost-pre和LLCER可克服这一困难,敏感度和特异度均达100%。

研究设计与样本

  • 回顾性研究纳入22例患者(肝细胞腺瘤6例、局灶性结节性增生16例),均行钆塞酸增强MRI;诊断由8例活检确立、13例由影像标准及随访确立。

关键影像表现/征象

  • 肝细胞腺瘤最特异的非增强MRI特征为病灶内脂肪(所有肝细胞腺瘤含脂肪,局灶性结节性增生均无);肝胆期所有局灶性结节性增生呈等或高信号,肝细胞腺瘤除1例外均呈低信号。

诊断标准与关键数值

  • SIRpost-pre和LLCER鉴别局灶性结节性增生与肝细胞腺瘤的敏感度和特异度均为100%;局灶性结节性增生的平均SIRpost-pre和LLCER显著高于肝细胞腺瘤(P < .001)。

临床应用与阅片要点

  • 阅片时可先观察非增强MRI病灶内脂肪以提示肝细胞腺瘤,再结合肝胆期信号及SIRpost-pre、LLCER定量分析辅助鉴别。

局限性

  • 本文为回顾性研究。
  • 作者指出病灶的定性特征可能不足以做出可靠诊断,肝胆期钆塞酸摄取存在重叠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the diagnostic performance of gadoxetic acid (Gd-EOB)-enhanced MRI for distinguishing focal nodular hyperplasia (FNH) from hepatocellular adenoma (HCA) in children.

METHODS: Twenty-two patients (HCA, n = 6; FNH, n = 16) underwent MRI with Gd-EOB were retrospectively included in this study. The diagnosis was established by biopsy in eight patients and by imaging criteria and follow-up in 13 patients. After qualitative analyses of MRI, quantitative analyses were performed by calculating the relative signal intensity ratios (SIR) between lesion and liver parenchyma both on precontrast and hepatobiliary phase (HBP) images. Two equations, SIRpost-pre and liver-to-lesion contrast enhancement ratio (LLCER), using both SIRs of precontrast and HBP imaging together were also calculated.

RESULTS: The most distinguishing non-contrast-enhanced MRI feature of HCA was intralesional fat since all HCA contained fat but none of FNHs. All FNHs were iso- or hyperintense relative to the adjacent liver on HBP images, but all HCAs except one were hypointense. The mean SIRpost-pre and LLCER of FNH were significantly higher than that of HCA (P < .001). SIRpost-pre and LLCER provided sensitivity and specificity values of 100%.

CONCLUSION: Although intralesional fat is a strong discriminative feature for distinguishing between HCA and FNH, qualitative properties of these lesions may not be enough for confident diagnosis. Gd-EOB uptake in the HBP provides high diagnostic accuracy, but overlap can be seen. SIRpost-pre and LLCER overcome the difficulties and have the best sensitivity and specificity.

ADVANCES IN KNOWLEDGE: Gadoxetic acid-enhanced MRI is a valuable tool for differentiation of FNH and HCA in children.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Erdemli Gürsel B, Öngen G, Candan S, et al. Gadoxetic acid-enhanced MRI in differentiating focal nodular hyperplasia from hepatocellular adenoma in children. Br J Radiol. 2025. PMID: 39570622. doi:10.1093/bjr/tqae222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。